Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Airsupra (PT027) in asthma
NCT03847896Phase 3Completed
- Sponsor
- Bond Avillion 2 Development LP
- Start
- Mar 2019
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of salbutamol + budesonide in asthma, sponsored by Bond Avillion 2 Development LP. Started Mar 2019; status: completed.
02
Drugs
salbutamol + budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03847896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03847896.